Brainstorm Cell Therapeutics Inc. Class Action Reminder: Contact Robbins LLP for Information About the BCLI Class Action
November 21, 2023 16:39 ET
|
Robbins LLP
Brainstorm Cell Therapeutics Inc. (BCLI) Misled Investors About the Viability and Efficacy of its drug NurOwn
Brainstorm Cell Therapeutics Inc. (BCS) Investor Notice: Robbins LLP Reminds Investors of Class Action Against Brainstorm Cell Therapeutics Inc.
November 08, 2023 15:32 ET
|
Robbins LLP
Brainstorm Cell Therapeutics Inc. (BCLI) Misled Investors About the Viability and Efficacy of its drug NurOwn
Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Brainstorm Cell Therapeutics Inc. (BCS)
November 03, 2023 15:59 ET
|
Robbins LLP
Brainstorm Cell Therapeutics Inc. (BCLI) Misled Investors About the Viability and Efficacy of its drug NurOwn